Brille Brian J
See Remarks
Brille Brian J has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, Brille Brian J is listed as See Remarks at Caris Life Sciences, Inc. Inside the rolling window, Brille Brian J reported no open-market purchases and 1 open-market sale totaling $12.1M in CAI.
Companies traded
Other insiders at CAI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brille Brian J made?
Brille Brian J has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Brille Brian J trade?
Brille Brian J has filed SEC Form 4 disclosures for 1 company, including CAI.
When was Brille Brian J's most recent SEC Form 4 filing?
Brille Brian J's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is Brille Brian J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brille Brian J is listed as See Remarks.
What is Brille Brian J's total buy and sell value in the current window?
Inside the rolling retention window, Brille Brian J bought $0 and sold $12.1M based on SEC Form 4 filings.
What was Brille Brian J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 400,000 CAI shares on 2026-09-17, worth $12.1M, per SEC Form 4 filings.